
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Metabolic Pattern in Healthy Subjects Given a Single Dose of Metformin: A Metabolomics Approach
Lina A. Dahabiyeh, Muhammad Mujammami, Tawfiq Arafat, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27
Lina A. Dahabiyeh, Muhammad Mujammami, Tawfiq Arafat, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Metformin and feeding increase levels of the appetite-suppressing metabolite Lac-Phe in humans
Barry Scott, Emily A. Day, Katie L. O’Brien, et al.
Nature Metabolism (2024) Vol. 6, Iss. 4, pp. 651-658
Open Access | Times Cited: 30
Barry Scott, Emily A. Day, Katie L. O’Brien, et al.
Nature Metabolism (2024) Vol. 6, Iss. 4, pp. 651-658
Open Access | Times Cited: 30
Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients
Lina A. Dahabiyeh, Refat M. Nimer, Khalid M. Sumaily, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Lina A. Dahabiyeh, Refat M. Nimer, Khalid M. Sumaily, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Harnessing Pharmacomultiomics for Precision Medicine in Diabetes: A Comprehensive Review
Dhoha Dhieb, Dana Mustafa, Maryam Hassiba, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 447-447
Open Access
Dhoha Dhieb, Dana Mustafa, Maryam Hassiba, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 447-447
Open Access
Metabolomic Approaches to Investigate the Effect of Metformin: An Overview
Hyun Woo Kim
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10275-10275
Open Access | Times Cited: 29
Hyun Woo Kim
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10275-10275
Open Access | Times Cited: 29
The metabolomics approach revealed a distinctive metabolomics pattern associated with hyperthyroidism treatment
Malak A. Jaber, Hicham Benabdelkamel, Lina A. Dahabiyeh, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
Malak A. Jaber, Hicham Benabdelkamel, Lina A. Dahabiyeh, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
Mass spectrometry-based metabolomics approach and in vitro assays revealed promising role of 2,3-dihydroquinazolin-4(1H)-one derivatives against colorectal cancer cell lines
Lina A. Dahabiyeh, Farah Hudaib, Wafa Hourani, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 182, pp. 106378-106378
Open Access | Times Cited: 11
Lina A. Dahabiyeh, Farah Hudaib, Wafa Hourani, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 182, pp. 106378-106378
Open Access | Times Cited: 11
Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications—Review
Mina Shahisavandi, Kan Wang, Mohsen Ghanbari, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 11
Mina Shahisavandi, Kan Wang, Mohsen Ghanbari, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 11
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
Charlotte Green, Thomas Marjot, John Walsby-Tickle, et al.
European Journal of Endocrinology (2022) Vol. 186, Iss. 3, pp. 367-377
Open Access | Times Cited: 18
Charlotte Green, Thomas Marjot, John Walsby-Tickle, et al.
European Journal of Endocrinology (2022) Vol. 186, Iss. 3, pp. 367-377
Open Access | Times Cited: 18
Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms
Daniel Gonzalez Izundegui, Matthew Nayor
Current Diabetes Reports (2022) Vol. 22, Iss. 2, pp. 65-76
Open Access | Times Cited: 16
Daniel Gonzalez Izundegui, Matthew Nayor
Current Diabetes Reports (2022) Vol. 22, Iss. 2, pp. 65-76
Open Access | Times Cited: 16
Targeting BCAA metabolism to potentiate metformin’s therapeutic efficacy in the treatment of diabetes in mice
Xiaoyun Zhao, Xuejiao Zhang, Jingjing Pei, et al.
Diabetologia (2023) Vol. 66, Iss. 11, pp. 2139-2153
Closed Access | Times Cited: 10
Xiaoyun Zhao, Xuejiao Zhang, Jingjing Pei, et al.
Diabetologia (2023) Vol. 66, Iss. 11, pp. 2139-2153
Closed Access | Times Cited: 10
Comprehensive metabolomics analysis reveals novel biomarkers and pathways in falsely suspected glutaric aciduria Type-1 newborns
Essa M. Sabi, Maha Almogren, Rajaa Sebaa, et al.
Clinica Chimica Acta (2024) Vol. 557, pp. 117861-117861
Closed Access | Times Cited: 3
Essa M. Sabi, Maha Almogren, Rajaa Sebaa, et al.
Clinica Chimica Acta (2024) Vol. 557, pp. 117861-117861
Closed Access | Times Cited: 3
Harnessing Oxylipins and Inflammation Modulation for Prevention and Treatment of Colorectal Cancer
Julius Gretschel, Racha El Hage, Ruirui Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5408-5408
Open Access | Times Cited: 2
Julius Gretschel, Racha El Hage, Ruirui Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5408-5408
Open Access | Times Cited: 2
Molecular and metabolic alterations of 2,3-dihydroquinazolin-4(1H)-one derivatives in prostate cancer cell lines
Lina A. Dahabiyeh, Wafa Hourani, Wesam Darwish, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Lina A. Dahabiyeh, Wafa Hourani, Wesam Darwish, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Lipids Alterations Associated with Metformin in Healthy Subjects: An Investigation Using Mass Spectrometry Shotgun Approach
Lina A. Dahabiyeh, Muhammad Mujammami, Reem H. AlMalki, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11478-11478
Open Access | Times Cited: 10
Lina A. Dahabiyeh, Muhammad Mujammami, Reem H. AlMalki, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11478-11478
Open Access | Times Cited: 10
Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
Khim Boon Tee, Luqman Ibrahim, Najihah Mohd Hashim, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1268-1268
Open Access | Times Cited: 8
Khim Boon Tee, Luqman Ibrahim, Najihah Mohd Hashim, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1268-1268
Open Access | Times Cited: 8
Investigating the effect of the probiotic Lactobacillus plantarum and the prebiotic fructooligosaccharides on Pseudomonas aeruginosa metabolome, virulence factors and biofilm formation as potential quorum sensing inhibitors
Bayan A. Al-Saafin, Amal G. Al‐Bakri, Salah Abdelrazig, et al.
Microbial Pathogenesis (2023) Vol. 177, pp. 106057-106057
Closed Access | Times Cited: 4
Bayan A. Al-Saafin, Amal G. Al‐Bakri, Salah Abdelrazig, et al.
Microbial Pathogenesis (2023) Vol. 177, pp. 106057-106057
Closed Access | Times Cited: 4
Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes
Najeha Anwardeen, Khaled Naja, Mohamed A. Elrayess
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Najeha Anwardeen, Khaled Naja, Mohamed A. Elrayess
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Metabolomics in diabetes mellitus: clinical insight
Shereen M. Aleidi, Hiba Fahmawi, Afshan Masood, et al.
Expert Review of Proteomics (2023) Vol. 20, Iss. 12, pp. 451-467
Closed Access | Times Cited: 3
Shereen M. Aleidi, Hiba Fahmawi, Afshan Masood, et al.
Expert Review of Proteomics (2023) Vol. 20, Iss. 12, pp. 451-467
Closed Access | Times Cited: 3
Earth Dreams: Reimagining ARPA for Health of People, Places and Planet
Alan Logan, Brian Berman, Susan L. Prescott
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 23, pp. 12788-12788
Open Access | Times Cited: 8
Alan Logan, Brian Berman, Susan L. Prescott
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 23, pp. 12788-12788
Open Access | Times Cited: 8
Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation
Andrew C. Elton, Vannesa Cedarstrom, Arman Quraishi, et al.
Nutrition and Cancer (2023) Vol. 75, Iss. 3, pp. 1014-1027
Closed Access | Times Cited: 2
Andrew C. Elton, Vannesa Cedarstrom, Arman Quraishi, et al.
Nutrition and Cancer (2023) Vol. 75, Iss. 3, pp. 1014-1027
Closed Access | Times Cited: 2
A pilot metabolomic study of drug interaction with the immune response to seasonal influenza vaccination
Amnah Siddiqa, Yating Wang, Maheshwor Thapa, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Amnah Siddiqa, Yating Wang, Maheshwor Thapa, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Metabolomics: A Pipeline for Biomarker Discovery in Genetic Diseases
Lina A. Dahabiyeh, Refat M. Nimer
(2023), pp. 43-69
Closed Access | Times Cited: 2
Lina A. Dahabiyeh, Refat M. Nimer
(2023), pp. 43-69
Closed Access | Times Cited: 2
Lipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker Potential
Muhammad Mujammami, Shereen M. Aleidi, Adriana Zardini Buzatto, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1717-1717
Open Access | Times Cited: 2
Muhammad Mujammami, Shereen M. Aleidi, Adriana Zardini Buzatto, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1717-1717
Open Access | Times Cited: 2
The metabolomics of a protein kinase C delta (PKCδ) knock-out mouse model
Du Toit Loots, Adetomiwa A. Adeniji, Mari van Reenen, et al.
Metabolomics (2022) Vol. 18, Iss. 11
Open Access | Times Cited: 3
Du Toit Loots, Adetomiwa A. Adeniji, Mari van Reenen, et al.
Metabolomics (2022) Vol. 18, Iss. 11
Open Access | Times Cited: 3
Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients
Evan Davis, Hua-Hsin Hsiao, Nancy Barone, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Evan Davis, Hua-Hsin Hsiao, Nancy Barone, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access